pluvicto
novartis europharm limited - lutetium (177lu) vipivotide tetraxetan - eturauhasen kasvaimet, kastraatio-resistentin - terapeuttiset radiofarmaseuttiset valmisteet - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.
xevudy
glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - immunoseerumit ja immunoglobuliinit, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.
nix 1 % shampoo
aco hud nordic ab - permethrin - shampoo - 1 % - permetriini
nix 5 % emulsiovoide
aco hud nordic ab - permethrin - emulsiovoide - 5 % - permetriini
permethrin morningside 50 mg/g emulsiovoide
morningside healthcare (malta) limited - permethrin - emulsiovoide - 50 mg/g - permetriini
perxine 50 mg/g emulsiovoide
infectopharm arzneimittel und consilium gmbh - permethrin - emulsiovoide - 50 mg/g - permetriini
mydrane 0.2 mg/ml + 3.1 mg/ml + 10 mg/ml injektioneste, liuos
laboratoires thea - lidocaine hydrochloride, phenylephrine hydrochloride, tropicamide - injektioneste, liuos - 0.2 mg/ml + 3.1 mg/ml + 10 mg/ml - tropikamidi
bayvantic vet paikallisvaleluliuos
bayer animal health gmbh - permethrin, imidacloprid - paikallisvaleluliuos - permetriini
ataxxa vet 2000 mg / 400 mg paikallisvaleluliuos
krka, d.d., novo mesto - permethrin, imidacloprid - paikallisvaleluliuos - 2000 mg / 400 mg - permetriini
ataxxa vet 1250 mg / 250 mg paikallisvaleluliuos
krka, d.d., novo mesto - permethrin, imidacloprid - paikallisvaleluliuos - 1250 mg / 250 mg - permetriini